[Chemotherapy of stage III and IV ovarian carcinoma]. 1980

J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo

UI MeSH Term Description Entries
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
January 1993, Clinical oncology (Royal College of Radiologists (Great Britain)),
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
October 1990, Nihon Gan Chiryo Gakkai shi,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
December 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
September 1993, Nihon Sanka Fujinka Gakkai zasshi,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
January 1980, Voprosy onkologii,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
January 1985, Progress in clinical and biological research,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
October 1978, La Nouvelle presse medicale,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
January 1986, Acta obstetricia et gynecologica Scandinavica,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
July 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J P Neijt, and J W Barents, and C P Vendrik, and A C van Lindert, and A Struyvenberg, and H M Pinedo
January 2012, Case reports in oncology,
Copied contents to your clipboard!